22k
3.6k
Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Read more

Turnover of pharmaceuticals in Sweden 2017, by type of pharmaceutical

Turnover of pharmaceuticals in Sweden in 2017, by type of pharmaceutical (in billion SEK)

by F. Norrestad, last edited Apr 12, 2019
Turnover of pharmaceuticals in Sweden 2017, by type of pharmaceutical This statistic shows the turnover of pharmaceuticals in Sweden in 2017, by type of pharmaceutical. That year, the turnover of subsidized prescriptions was by far highest, reaching approximately 27 billion Swedish kronor.
Show more

Turnover of pharmaceuticals in Sweden in 2017, by type of pharmaceutical (in billion SEK)

Turnover in billion SEK
--
--
--
--
Turnover in billion SEK
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account
only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1.5m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account
only $49 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

© Statista 2019

About this statistic

Show source

Download Settings Share
Download started
Please be patient - this may take a moment
by F. Norrestad, last edited Apr 12, 2019
This statistic shows the turnover of pharmaceuticals in Sweden in 2017, by type of pharmaceutical. That year, the turnover of subsidized prescriptions was by far highest, reaching approximately 27 billion Swedish kronor.
Show more

Other statistics on the topic

AstraZeneca's top products based on revenue 2015-2018

AstraZeneca's top products based on revenue 2015-2018

AstraZeneca's revenue 2006-2018

AstraZeneca's revenue 2006-2018

Annual revenue of Recipharm 2007-2017

Annual revenue of Recipharm 2007-2017

Annual profit/loss of Recipharm 2007-2017

Annual profit/loss of Recipharm 2007-2017

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Pharmaceutical industry in Sweden
Pharmaceutical industry in Sweden

All Information
in one Presentation

Pharmaceutical industry in Sweden
  • 55 page/s
  • English
  • pptx
  • Detailed references

Everything On "Pharmaceutical industry in Sweden " in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Go to dossier
Other Reports & Dossiers
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Pharmaceutical industry in Sweden "
  • Overview
The most important statistics
  • Trade
  • Key players
  • R&D, patents and new products
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
Topics
Market Analytics
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

Menu